Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia
Clinical trial NCT03348033 · UNKNOWN
Trial details
- NCT number
- NCT03348033
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.